However, a deeper understanding of the tumor microenvironment owing to the development of immunotherapy led to the identification of TGFβ, which plays an important role in enabling cancer cells to escape the immune system by activating and differentiating the surrounding immune cells [13, 14, 44]. The gene discussed is TGFB1; the disease is neoplasm.